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INTRODUCTION 
Organic phosphorus compounds (OPC) groups of cholinesterase 
inhibiting insecticides that most commonly produces toxicity in humans. 
In clinical practice all insecticides with a ‘P’ atom in their molecular 
structure that possesses cholinesterase inhibition are considered as 
OPC’s,but there are other compounds also possessing the P atom in their 
molecule that also have property of cholinesterase inhibition 
(e.g.:phosphoric acids and phosphonates). Some contain thioesters 
(e.g.:parathion), others are vinyl esters. 
 All those that have property of cholinesterase-inhibition 
(anticholinesterases) that contain phosphorus atom in their molecule will 
be collectively called as OPC’s. OPC’s act by inhibiting the enzyme 
acetylcholinesterase thereby increasing the acetylcholine levels in the 
nicotinic and muscarinic receptors. This increased Ach will produce the 
features of cholinergic excess syndrome1 
The most common mode of death in OPC poisoning is respiratory 
failure. Most common OPC poisonings are suicidal especially in rural 
Indian populations. Its high mortality and easy availability for the people 
involved in agriculture related work which makes it ideal suicidal agent 
for people living in rural India.2 
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Most of the OPC poisoned patients are managed in ICU settings. 
And the new advanced treatment modalities have resulted in increased 
survival in these patients. Such measures are also prolong the in-hospital 
stay and increases the hospital expenses. So there is a need  for 
prognostication of these patients and also for avoiding expensive 
procedures and treatments. 
The Glasgow Coma Scale is an effective bed side tool to assess the 
conscious level of any patient. Although it was initially devised for 
assessing patients with head injury, there is ample evidence to advocate 
its use for patients presenting with single or mixed poisonings. The QTC 
interval is an emerging marker of severity in acute OP poisoning. 
Multiple studies have indeed demonstrated an association between QT 
interval and patient outcomes in acute OP poisoning.  
Thus the need for study arises due to the convergence of following points: 
1. To identify the predictors of mortality in acute OP poisoned 
patients. 
2. To evaluate and compare the performance of Glasgow Coma Scale 
and QTC interval in predicting the outcomes of patients poisoned 
with organophosphorus insecticide compounds.  
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AIMS AND OBJECTIVES 
The aim of our study is to compare the Glasgow Coma Scale and the QTC 
interval in predicting the severity and the clinical outcome of patients 
admitted with acute organophosphate insecticide poisoning.  
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REVIEW OF LITERATURE 
THE GLOBAL PROBLEM 
Globally, more people are killed each year by acute poisoning of 
anticholinesterase insecticides than by any other xenobiotic. In Asia alone 
, around 2 lakh people succumb to toxic organic phosphorus insecticides, 
mostly from deliberate self ingestion. Around 3000 to 6000 ventilators 
are required in Asia alone at any given point of time to provide ventilator 
support to these poisoned patients4. When a poisoning with 
organophosphate occurs, it often requires intensive care along with long 
hospital stays, significantly adding to the healthcare expenditure in the 
high prevalence areas like India. 
A pesticide is defined as a chemical used to prevent , destroy or 
repel a pest. A pest can be an insect, a rodent, a weed or any unwanted 
organism. Pesticides are unique in the aspect that they are deliberately 
added to the environment for killing some form of life. An ideal pesticide 
should be target specific i.e. it should only kill what it is intended to kill. 
Unfortunately, all the pesticides that are in use today are not target 
specific, they are widely toxic to many non target species, including 
humans.  
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A pesticide is equivalent to a pharmaceutical agent. There dozens 
of classes of pesticides, each with different uses, different mechanism of 
action and therefore exert different toxic effects on non target hosts like 
humans. The pesticides are commonly classified according the species 
upon which they act on. The four major classes are as follows: 
• Insecticides 
• Herbicides 
• Fungicides 
• Rodenticides  
Other classes include- acaricides, larvicides and molluscides. By 
convention, plant growth factors and plant hormones are also classified 
under the category of pesticides.  
Within each of the above said classes there are several subclasses, 
divided on the basis of the chemical structure of the individual 
compounds. For example insecticdes are further divided into 
organophorus compounds, carbamates, organochlorines and pyrethroids 
and so on. The in depth toxicological knowledge regarding a particular 
agent is needed to understand its effects on non target organisms. 
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HISTORY AND EPIDEMIOLOGY 
Tetraethylpyrophosphate was the first potent synthetic 
organophosphorus compound. It was synthesised by Clermont in the year 
18545. Later in 1932, Lange and Kruegger reported choking and blurring 
of vision after inhaling fumes of dimethyl and diethyl 
phosphorofluoridates. Following this report, Schrader began working on 
these compounds in Germany, initially for use as insecticides but later on 
for use in war. Schrader and his colleagues synthesised hundreds of 
compounds, including the popular insecticide parathion and various other 
nerve agents used in war, like sarin, soman and tabun. Since that time, 
more than 50,000 compounds have been synthesised as insectides. More 
than a dozen such compounds are now being produced commercially. 
Organic phosphorus compounds(OPs) are a group of insecticides 
that inhibit the cholinesterase enzyme and commonly produce human 
toxicities. The term “organophosphate” is a clinical one, and it refers to 
any phosphorus containing insecticide that has anticholinesterase activity. 
The phosphate group contains a central phosphorus atom linked to four 
oxygen atoms. There are other derivatives of phosphoric and phosphonic 
acids that exhibit anticholinesterase activity; they are also grouped under 
organophosphate insecticides. 
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The anticholinesterase compounds are broadly grouped according 
to their toxicities by the world health organisation’s classification of 
insecticides into five groups. They are as follows: 
• Class Ia: “extremely hazardous” 
• Class Ib: “highly hazardous” 
• Class II: “moderately hazardous” 
• Class III: “slightly hazardous” 
• Class IV: “active ingredients unlikely to produce acute hazard in 
normal use.” 
 
WHO RECOMMENDED CLASSIFICATION OF PESTICIDES BY 
HAZARD8 
This is based on the study of the minimum lethal dose of the agent 
in rats. This helps to identify the highly toxic ones from the less lethal 
ones. The following table shows the WHO poison classification.   
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Patients usually present following an accidental or suicidal 
ingestion of the compound or after working in an area that was recently 
sprayed with the insecticide. Children or adults may also present with 
toxicity resulting from playing or living in a house or a field fogged or 
sprayed with these agents. Direct skin contact with certain agents can be 
rapidly poisonous. Outbreaks of poisoning due to contamination of water 
sources or crop produce is a common occurrence in the developing world. 
Poisoning is also seen in those involved in the illegal production and 
export/import of these compounds. Organophosphorus insecticide agents 
have also been used for committing homicides. 
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An estimated one million to two million poisonings due to 
organophosphates occur in Asia region alone. This is based on the 
following data. The case fatality ratio in poisoning with OPs is around 
10% to 20% and about two lakh patients die due to organophosphate 
poisoning every year. Respiratory failure remains the most common 
cause of death in this patient group. It is estimated that OP poisoned 
patients require on an average, 1.1-2.3 million days of ventilator support. 
This means that about 3140 to 6280 ventilators are being used every year 
only to provide ventilator support to patients developing respiratory 
failure secondary to OP poisoning. 
The mortality from organophosphate poisoning largely depends on 
the compound, route of exposure, amount ingested and most importantly 
the availability of prehospital resuscitation services and intensive care 
facilities in the hospitals. Even with prompt medical attention in an 
adequately equipped facility, a patient who has ingested a potent 
compound like parathion may not survive even the duration of ambulance 
transport. Among those who survive to reach the hospital , most of them 
would have developed hypoxic brain damage. Even though the hospital 
mortality rates of these patients are around 20% to 30%, it is a falsely low 
value due to the reasons stated above. Data from Munich toxicology 
intensive care unit in Germany, state that the mortality of patients 
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presenting with acute parathion poisoning was 40%. In a developing 
country like India, where healthcare facilities are sparse, very few 
patients survive acute Organophosphate poisoning. 
The easy availability of the highly toxic organophosphates in India 
coupled with the lack of adequate health care facilities especially in the 
rural areas, make acute poisonings with organophosphate insecticides 
highly fatal. 
Organophosphates are the most lethal pesticides that are in 
household and agricultural use today. The acute OP poisoning is also one 
of the most lethal poisonings in the world today. Strict regulation of the 
manufacture and sale of these compounds is necessary to prevent 
accidental and suicidal poisonings. Such a measure would substantially 
reduce the mortality and morbidity and lowering the health care 
expenditure of the State. 
 
PHARMACOLOGY 
Poisoning from organophosphate compounds results in a rise in 
concentration of Acetylcholine(ACh) at the muscarinic and nicotinic 
nerve endings, thus causing a cholinergic storm. 
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DIAGRAM SHOWING THE GENERAL CHEMICAL 
STRUCTURE OF AN ORGANOPHOSPHORUS COMPOUND 
The general structure of  organo phosphorus insecticide. X 
represents the leaving group. R1 and R2 may be aromatic or aliphatic 
groups that can be identical. The “X” group or the leaving group of the 
organophosphorus insecticide determines many of the characteristics and 
it also provides a means to classify these compounds into four main 
groups. 
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CLASSIFICATION OF OP ACCORDING TO THE LEAVING 
GROUP 
Group 1: phosphorylcholines 
Group 2: fluorophosphates 
Group 3: cyanophosphates 
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Group 4: widest of all groups. All the available OPs today belong to this 
group.  They are usually a dimethoxy or a  diethoxy compound. 
The organophosphates can be direct acting or indirect acting. 
Direct acting OPs:  
The “oxons”. They do not require activation. They directly bind to 
and inhibit the acetyl cholinesterase enzyme. 
Indirect acting OPs:  
The “thion”. They are inactive prodrugs. They are activated by 
desulfuration to produce the active oxon form. This activation reaction 
occurs in the intestinal mucosa or in the liver after absorption.9 
Mechanism of action: 
Normally the acetyl choline released into the neuromuscular 
junction is metabolised  by   acetyl cholinesterase to choline and acetic 
acid.  
The OP binds with the active site on AChE enzyme. The enzyme 
hydrolyses the OP molecule. In the process a covalent bond forms 
between the OP and the AChE resulting in the inactivation of the enzyme. 
Although the hydrolysis reaction occurs in a few microseconds, the 
breakage of the covalent bond requires minutes to hours. The covalent 
bonding is initially reversible. The half life of this bond depends on the 
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nature of the OP compound. The in vitro half life for spontaneous 
reactivation of human acetylcholinesterase for dimethoxy compounds is 
o.7 to 0.86 hours, whereas for the diethoxy compounds it is between 31 
and 57 hours. Thus spontaneous reactivation of the AChE enzyme is 
faster with dimethoxy OPs. 
The administration of oximes like pralidoxime hastens the 
reactivation of the acetylcholinesterase enzyme10. However, if the 
organophosphate is bound with the AChE for a long period as in case of 
delayed administration of oxime or inadequate dosing, then the OP loses 
an alkyl group i.e. the “R” group from its molecule non enzymatically. 
This results in permanent inactivation of the acetylcholinesterase enzyme. 
This process is known as “Aging”. The in vitro half life of aging of the 
human AChE enzyme is around 4 hrs with dimethoxy OPs; with diethoxy 
compounds it is 31 hours. These findings have important clinical 
implications. Clinically it means that if a patient presents with poisoning 
due to a dimethoxy compound after 4 hours, it means that 50% of his 
AChE would have been inactivated permanently by aging; by 14 hours 
nearly all of his enzyme would have undergone aging. In case of the 
diethoxy compounds , however, a patient presenting at 14 hours would 
have very little AChE destroyed by aging and will still be responsive to 
pralidoxime or obudoxime. The activity of the AChE lost due to aging 
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can be regained only through De novo synthesis of the enzyme. Therefore 
early diagnosis and prompt administration of oximes is crucial in 
improving the overall outcome of the patient.  
The OPs also vary in their lipid solubility, the rate of conversion 
from thion to oxon, rate of AChE inhibiton and the degree of inhibition of 
the butyrylcholinesterase activity in the plasma. Some of the OP may not 
be classified under dimethoxy or diethoxy group. They contain an alkyl 
or aryl group linked to the phosphorus atom by a sulphur atom instead of 
an oxygen atom. These compounds exhibit very rapid aging compared to 
the other two.  
Spontaneous reactivation of the AChE, aging, metabolism and 
elimination of OP are competing processes. Their kinetics are poorly 
defined. Therefore it is very difficult to predict the course of any 
particular organophosphorus compound in an individual.  
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PHARMACOLOGIC PROPERTIES OF DIMETHOXY 
ORGANOPHOSPHATE COMPOUNDS 
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The mechanism of inhibition of acetylcholinesterase by a organic 
phosphorus compound. With prolonged binding one of the R groups in 
the OP is lost nonenzymatically resulting in “aging”.  
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Normal metabolism of 
acetylcholine by 
acetylcholinesterase 
PHARMACOLOGIC PROPERTIES OF DIETHOXY 
COMPOUDS 
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PHARMACOKINETICS AND TOXICOKINETICS 
Routes of entry 
Organophosphates are well absorbed from lungs, gastrointestinal 
tract, mucous membranes, and conjunctiva after an exposure by oral 
ingestion, inhalation of fumes or direct contact. OPs are absorbed through 
albeit to a limited extent. But in exposure to toxic agents , cutaneous 
absorption itself may be rapid enough to be lethal. Topical absorption is 
increased in the presence of cuts in the skin, dermatitis and in areas with 
high environmental temperature.  
Absorption and distribution 
The time to attain peak plasma concentration following an acute 
poisoning is unknown. Studies done in human volunteers , using very low 
doses of chlorpyrifos showed that the Cmax can be about 6 hours following 
ingestion. But in patients ingesting large quantities or in cases of 
poisoning with the fast acting thions, symptoms occur in matter of 
minutes suggesting the absorption in such cases is rapid.  
Most OPs are lipophilic compounds, so their volume of distribution 
will be very large. These lipophilic OPs rapidly distribute into fat and 
tissue , and are consequently protected from metabolism. Studies done by 
injecting radiolabelled parathion into mice showed that it rapidly 
20 
 
accumulated into the brown fat and the salivary glands; high 
concentrations were seen in kidneys, liver and adipose tissue. Gradually 
the adipose tissue went on to accumulate the highest concentration of the 
insecticide. The parathion was measurable in blood upto 48 days post 
exposure due to slow release from the adipose tissue.  
The slow release of the lipophilic compounds from their can cause 
the cholinergic crisis to recur days after the acute exposure. This is more 
likely with compounds fenthion and diclofenthion which have high fat 
solubility. Dimethoate, methamidophos, and oxydemeton methyl are OP 
compounds that have low fat solubility; therefore they have smaller 
volume of distribution and have high serum concentrations after 
exposure.  
Metabolism  
The thion molecules are activated by the cytochrome P 450 
enzymes in liver and intestinal mucosa. The exact enzymes that are 
responsible vary according the concentration of the OP. for example, 
parathion , malathion, chlorpyrifos and diazinon are activated by the 
enzymes CYP1A2 and CYP2B6 at low serum concentrations. But at high 
serum concentrations, as in case of self poisoning , CYP3A4 becomes the 
dominant enzyme. The enzymes that are involved in the inactivation of 
the oxon metabolites are not known.  
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Role of Paraoxonase 
Paraoxonases are enzymes that hydrolyses the active oxon 
metabolites of some OPs. Many studies were done to determine the 
relationship between human paraoxonase activity and their susceptibility 
to acute and chronic OP poisoning12. The activity of this enzyme differs 
significantly among different species. In animal studies, exogenous 
administration of the paraoxonase enzyme resulted in protection against 
toxic effects of OPs, whereas Paraoxonase knockout mice showed 
increased susceptibility to the toxicity of OPs11. Many authors opine that 
the polymorphisms in human paraoxonase enzyme may be the reason for 
the interindividual variations in susceptibility to OPs.  
PATHOPHYSIOLOGY 
Acetylcholine(ACh) is a neurotransmitter found in the sympathetic 
and parasympathetic ganglia, skeletal muscle NMJ, post ganglionic 
sympathetic nerve endings in sweat glands, all post ganglionic 
parasympathetic nerve endings and in some synapses in the brain. When 
the action potential arrives at the presynaptic nerve terminal, the ACh 
containing vesicles fuse with axonal membrane and release ACh into the 
synapse/NMJ. The ACh binds to its receptor in the cyton of the post 
synaptic nerve and activates signalling pathways- G protein coupled 
receptors for muscarinic and ligand gated ion channels for nicotinic 
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receptors- resulting in depolarisation and propagation of the action 
potential.  
Organic phosphorus insecticides inhibit the carboxylic ester 
hydrolases in the body. It includes: 
• Acetylcholinesterase 
• Butyrylcholinesterases 
• Plasma and hepatic carboxylesterases 
• Paraoxonases 
• Chymotrypsin and other non specific proteases.  
As stated earlier, the acetylcholinesterase hydrolyses acetylcholine 
into choline and acetyl molecules. The choline is taken back by the 
presynaptic nerve terminal for resynthesis of the acetylcholine in the 
vesicles. The AChE is found in human nervous tissue, skeletal muscle 
NMJ and the red blood cells. The AChE activity in the RBC correlates 
with the enzyme activity in the nervous system, in cases of acute OP 
poisoning. 
The butyrylcholinesterase is synthesised by the liver. It is found in 
plasma; also seen in heart, liver , brain and pancreas. The function of this 
enzyme is not clearly understood. Its activity can be easily measured. It 
has important implication in anesthesia.  
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The inhibition of the acetylcholinesterase is thought to account for 
all of the manifestations of the OP  poisonings. However, clinical 
implication of the inhibition of the other enzymes is not clearly 
understood.  
In addition, it is worthwhile to note that people ingest commercial 
formulations and not the pure compounds. EACh OP compound is sold as 
an emulsifiable liquid. The active OP compound is mixed in an organic 
solvent such xylene or cyclohexanone1 and a surfactant. This combination 
is optimised by a company for eACh OP compound it manufactures. 
Therefore, there will be difference in the same OP compound sold by two 
companies and in two different OPs sold by the same company. 
The clinical effect of ingestion of these coformulants is not clearly 
studied and is uncertain. The solvent themselves have low toxicities. 
However, there is a report of death of a minipig within minutes of 
exposure to dimethoate formulated with xylene solvent. The RBC 
cholinesterase was reduced by only 30%, indicating a possible non AChE 
related mechanism. Early work has shown that toxicity of dimethoate can 
be altered by changing its solvent. 
Following OP poisoning patients develop rapid loss of 
consciousness and respiratoy failure. This can result in aspiration with the 
OP, solvent and surfactant. The solvent and surfactant , after aspiration, 
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produce a chemical pneumonitis. This aspiration pneumonia is not 
responsive to oximes or atropine.  
 
MECHANISM OF ACTION OF ACETYLCHOLINE AT THE NEUROMUSCULAR JUNCTION 
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CLINICAL MANIFESTATIONS 
The clinical features of acute toxicity result from the presence of 
excess acetylcholine at the muscarinic and nicotinic cholinergic receptors 
, resulting in their overstimulation. The clinical presentation is one of a 
cholinergic excess. 
THE AUTONOMIC MANIFESTATIONS ARE: 
1. Salivation  
2. Lacrimation 
3. Urination 
4. Diarrhoea  
5. Gastric hypersecretion 
6. Emesis 
7. Bronchospasm  
8. Bronchorrhea (can mimic pulmonary edema)15 
9. Miosis 
Of the above mentioned features , miosis is the most commonly 
encountered sign. Bronchorrhea can be so profuse that patients “drown” 
in their own secretions. These are features of muscarinic stimulation. 
Features of nicotinic stimulation are predominantly seen at the 
skeletal muscles. The effects are similar to that of the depolarising muscle 
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relaxant succinylcholine. There are initial fasciculations of muscle fibres 
followed by paralysis. This effect is described as the most reliable sign of 
parathion toxicity. Cranial nerve paralysis is uncommon. A rare patient 
may present only with the nicotinic features of paralysis without other 
attend cholinergic symptoms. Extrapyramidal system involvement is 
uncommon; if present , it persists for several days following resolution of 
the cholinergic features. 
Sometimes muscarinic signs may be absent or may not be 
clinically predominant. The parasympathetic effect may be offset by the 
excessive stimulation of the nicotinic receptors of the sympathetic 
nervous system(resulting in excess catecholamine release). Such patient 
may present with mydriasis, bronchodilation, tachycardia and urinary 
retention.  
The onset of symptoms will vary depending on the  
• Route of exposure  
• Degree of exposure 
o Patients ingesting large quantities of compounds will have a 
rapid inhibition of the AChE enzyme, consequently they 
exhibit toxicity earlier- as early as 5 minutes after 
consumption. 
o  
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• The OP compound consumed. 
o The oxon OPs are direct acting agents. Consequently , 
patients become symptomatic very soon after ingestion. 
There is a case report of a man who died within fifteen 
minutes of Mevinphos ingestion.  
o Some thion OPs are rapidly converted to their active form. 
classical example is parathion. Patients become unconscious 
within minutes after consumption of parathion.  
o Lipid solubility also affects the onset. The more lipid soluble 
agents like Fenthion are rapidly redistributed to fat stores. 
The onset of symptoms is delayed – respiratory failure after 
Fenthion ingestion can occur 24 hours following ingestion. 
The less lipophilic agents manifest their toxicity much 
earlier.  
Duration of symptoms following poisoning is variable. The 
lipophilic compounds like fenthion can cause recurrent cholinergic crisis 
many days after the initial ingestion due to delayed release from the fat 
stores13,14.  
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CENTRAL NERVOUS SYSTEM EFFECTS OF OPs: 
Many patients are awake and alert and they complain of , 
• Anxiety 
• Restlessness 
• Insomnia 
• Headache 
• Dizziness 
• Blurred vision 
• Depression 
• Tremors 
• And many other non specific symptoms. 
The level of consciousness falls rapidly following poisoning, 
resulting in confusion, lethargy and coma. Many careful observational 
studies have shown that convulsions do not occur due to OP poisoning. If 
convulsions occur, they are commonly   secondary to hypoxia rather than 
the cholinergic toxicity. 
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METABOLIC EFFECTS: 
The increased adrenergic drive results in the following:- 
• Leucocytosis15,17 – the increased adrenergic stimulation results in 
demarginalisation of white blood cells.  
• Glycogenolysis and Ketosis – the excess adrenergic drive causes 
glycogenolysis resulting in hyperglycemia and ketosis simulating 
ketoacidosis18,19. However the disturbances in glucose metabolism 
are uncommon. A study conducted recently showed that out of 79 
patients poisoned with OP or carbamate only six patients showed 
hyperglycemia. In an older study, 7 out of 105 patients had 
hyperglycemia. It is possible that the effect on glucose metabolism 
may be specific effects of individual compouds rather than all OPs 
in general. Further studies with individual compounds are needed 
to study the association .  
• Hyperamylasemia20 – it is a relatively common finding in OP 
poisoning. The amylase likely comes from pancreas; animal studies 
have shown OP induced pancreatic damage. Pancreatic edema and 
/or necrotising pancreatitis have been in reported in human 
poisonings21. The incidence of the pancreatitis varies with different 
compounds and also with their coformulants.  
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• Elevation of liver enzymes also occurs secondary to acute OP 
poisoning.  
CARDIOVASCULAR MANIFESTATIONS: 
The cardiovascular manifestations reflects the mixed effects the 
autonomic nervous system and also the effects of OP induced hypoxia 
and hypovolemia.  
• Heart rate-bradycardia is seen relatively few patients. Patients who 
had received atropine before reaching the hospital may exhibit 
tachycardia.  
• QT interval-There are several reports in literature describing the 
prolongation of the QT interval and its associated arrhythmias in 
patients with acute OP poisoning. This may be confounded by the 
presence of hypoxia and hypotension secondary the effect of OP 
poisoning. Majority of  patients with QT prolongation succumb to 
dysrrthmias.  
• Hypotension- the excess circulating ACh acts on vascular receptors 
causing vasodilation and consequent hypotension. Severe 
hypotension is particularly seen in Dimethoate poisoning22. This 
hypotension is only partially responsive to inotropes. It is not 
known whether it is due to the vasodilatation or to direct 
cardiotoxic effect of dimethoate.  
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PATHOPHYSIOLOGY OF THE CHOLINERGIC SYNDROME 
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RESPIRATORY COMPLICATIONS: 
• Bronchorrhea and bronchoconstriction – occurs secondary to 
muscarinic stimulation. They respond to adequate atropine therapy. 
• Weakness of intercostal muscles and diaphragm resulting in 
respiratory failure. Respiratory failure is the most common cause 
of death in acute OP poisonings.  
• Loss of central respiratory drive. 
     The respiratory failure secondary to muscle paralysis does not 
respond to atropinisation. Patients need adequate ventilator support till 
the muscle power is regained.  
     Aspiration of the coformulated pesticides results in aspiration 
pneumonia due to the hydrocarbon in the coformulants. The 
hydrocarbon causes aspiration pneumonia, chemical pneumonitis and 
acute respiratory distress syndrome.  
 
DELAYED SYNDROMES 
• INTERMEDIATE SYNDROME 
• ORGANIC PHOSPHORUS INDUCED DELAYED 
NEUROPATHY 
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INTERMEDIATE SYNDROME 
A syndrome of delayed muscle weakness causing respiratory 
failure , without cholinergic features was first reported in the year 197424 
and later in 1987.  
“Intermediate Syndrome” is defined as the muscle weakness that 
occurs 24 to 96 hours following OP poisoning and after resolution of the 
cholinergic crisis.25 
It typically involves the proximal muscle groups especially the 
neck flexors, cranial nerves and can progress to cause respiratory failure 
that can last for several weeks. Consciousness is not impaired unless there 
is hypoxia or a pneumonia. Weakness of neck flexion is often the first 
sign. This can be easily assessed at the bed side by asking the patient to 
lift his head off the pillow. Recognising this syndrome is very important 
because an apparently well patient can suddenly progress to respiratory 
failure and even death, if not promptly treated.  
The exact pathophysiology of this syndrome is not clear at present. 
It occurs due to the dysfunction of NMJ, the involvement of the 
intercostal muscles and diaphragm results in respiratory failure. It 
postulated that the excess stimulation of the NMJ during the cholinergic 
crisis results in dysfunction26; the dysfunction takes a longer to repair 
thus explaining the long duration of this syndrome.  
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Many case reports and small case series around the globe have shown that 
the intermediate syndrome is more with certain OP compounds than 
others. They are malathion, fenthion, methylparathion and parathion. Two 
large cohort studies have shown that IMS is more common with fenthion 
poisoning than with malathion, chlorpyrifos or fenitrothion poisoning.  
The IMS is just one manifestation of the OP induced NMJ 
dysfunction in the peripheral nerves29. The relative incidence and timing 
of the IMS depends on the rapidity and quantity of the 
Acetylcholinesterase inhibition. Fat insoluble OPs like dimethoate have 
very high blood concentrations , therefore the enzyme inhibition is also 
intense. Hence, the NMJ dysfunction develops earlier, even before the 
cholinergic crisis resolves. Fat soluble compounds like fenthion, have 
lower blood levels with large redistribution. They cause protracted 
inhibition of the AChE enzyme. Thus the respiratory failure and the NMJ 
dysfunction with fenthion occurs later27.  
There is also a school of thought that insufficient oxime therapy 
results in development of intermediate syndrome30. For example , 
chlorpyrifos responds very well to oxime therapy. Prompt and adequate 
oxime therapy in chlorpyrifos poisoning prevents intermediate syndrome. 
Whereas, in case of dimethoate or malathion poisoning, the enzyme 
inhibition poorly responds to oxime therapy. In such poisonings , oxime 
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therapy may not be able to prevent occurrence of intermediate syndrome. 
Overall, the dysfunction of the NMJ may be secondary to inadequate 
oxime therapy( as in chlorpyrifos poisoning) or because of the 
unresponsiveness of the AChE inhibition to oximes(as in case of 
malathion poisoning).  
DIAGNOSIS OF INTERMEDIATE SYNDROME 
1. Clinical examination remains the most reliable way to diagnose 
IMS.  
2. Electromyography (EMG) shows tetanic fade in IMS, indicating 
both pre and post synaptic involvement. More recent works have 
shown that decrement – increment phenomenon occurs in IMS. 
This is seen prior to the development of neurological features and 
respiratory failure28.  
TREATMENT  
• Treatment is mainly supportive, airway management and 
mechanical ventilator support for respiratory failure.  
• Pralidoxime and atropine donot have a role in treating the IMS 
per se. atropine may be used on a sos basis for control of 
cholinergic crisis , if it occurs. Pralidoxime may be able to 
reverse the IMS if given early in the course of illness. It is 
36 
 
unlikely to produce any benefit if administered after the onset of 
NMJ dysfunction.  
• The duration of IMS is typically 5 to 18 days31.  
 
ORGANIC PHOPHORUS-INDUCED DELAYED NEUROPATHY 
(OPIDN) 
Peripheral neuropathies can occur following chronic exposure to 
organophosphates or after an acute poisoning. OPIDN occurs to 
inhibition of an enzyme in the nervous tissue known as the 
NTE(neuropathy target esterase) , now identified as the 
lysophospholipase(lysoPLA). OPs inhibit the enzyme by 
phosphorylation. The lysoPLA is involved in degrading 
phosphatidylcholine of the endoplasmic reticulum. The loss of the NTE-
lysoPLA activity results in accumulation of the membrane phospholipids 
in the nerve tissue, affecting the axonal transport and glial-axonal 
interactions.  
OPIDN can result from exposure to OPs that neither inhibit the 
RBC cholinesterase nor produce any cholinergic symptoms. Examples of 
compounds that commonly cause OPIDN include triaryl phosphates like 
mephosfolan, mipafox and chlorpyrifos. Pathologic studies demonstrate 
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the predominant involvement of distal large fibres; axonal degeneration 
occurs followed by demyelination33.  
Patients present with pain and weakness of the distal muscles 
which can progress to paralysis. Pyramidal tract signs occur weeks to 
months after the onset. The administration of atropine or pralidoxime 
does not have any effect on the course of the illness. EMGs and Nerve 
Conduction studies are useful in diagnosing the condition and also to 
differentiate it from other similar diseases like Guillian-Barre syndrome.  
Recovery is variable, takes months to years. Patients often have residual 
neurologic deficits.  
CHRONIC TOXICITY 
This results from chronic exposure to excessive amounts of OPs. 
This is commonly seen in agricultural workers using these pesticides, 
those involved in their manufacture and also in those who have repeated 
contact with pesticides in their households. Cholinergic ophthalmic can 
also produce toxicity on chronic usage. Patients development symptoms 
after exposure for long period. Symptoms may range from non specific 
complaints like weakness and blurred vision to cholinergic symptoms like 
vomiting, diarrhoea and diaphoresis35,36,37. Measurement of 
butyrylcholinesterase activity in the plasma is the most sensitive test to 
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detect chronic exposure. Workers in contact with OP should have their 
baseline BuChE levels tested for future comparison and monitoring38,39 .  
Recent reports have linked parkinsons disease with exposure to 
OP40. There appears to be a genetic susceptibility for this condition. 
Extrapyramidal movement disorders have also been described after acute 
poisoning with OPs. However, detailed statistical analysis of 
epidemiologic studies have failed to find a link between chronic OP 
exposure and parkinsonism.  
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BEHAVIORAL TOXICITY: 
Acute or chronic exposure to OPCs also associated 
withbehavioural toxicity. Symptoms include confusion, anxiety, 
psychosis,depression, drowsiness, fatigue, and irritability. 
Electroencephalographicchanges may be seen and lasts for weeks41. 
Morphologic changes in thebasal ganglia of one child identified with 
single photos emissioncomputed tomography scan (SPECT) following 
poisoning. Studies haveshown a cognitive processing deficit after acute 
OPCs self-poisoninglasting for at least six months and this is not found in 
matched populationswho had poisoned themselves with 
Acetaminophen42,43. So far there is noclear evidence for neuro-psychiatric 
deficiencies resulting fromsubclinical exposure to OPCs. 
 
DIAGNOSTIC TESTING 
When a patient presents with features of cholinergic crisis to the 
emergency with a history of exposure to a OP pesticide, the diagnosis is 
straightforward and clear. Textbooks list a variety of clinical signs of 
cholinergic crisis like DUMBELS SLUD. Most patients with severe 
poisoning can be easily identified by the presence of miosis, excessive 
sweating and breathing difficulty. In situations where the history of 
pesticide exposure is not forthcoming, the clinician has to resort to other 
means to confirm the diagnosis of OP poisoning. However, the treatment 
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of a critically ill patient presenting with a cholinergic syndrome must not 
await the confirmation of the diagnosis.  
 
Laboratory tests that are used for the diagnosis of OP poisoning are: 
• Measuring the insecticide levels or their active metabolites in the 
biologic tissues.46,47,48 
• Estimation of cholinesterase activity in the plasma or blood.  
Although tests are available to detect OP compounds in blood and 
urine, their results are not available immediately. The normal reference 
range for many pesticide compounds have not been established. So, the 
diagnosis of anticholinesterase poisoning solely relies on the 
measurement of cholinesterase activity.  
 
CHOLINESTERASE ACTIVITY 
The two cholinesterases that are commonly measured are: 
• Butyrylcholinesterase (BuChE, plasma cholinesterase, EC 
3.1.1.8) 
o It is produced by the liver and secreted into the blood. 
o It metabolises xenobiotics like succinylcholine and cocaine.  
• Red blood cell cholinesterase(AChE 3.1.1.7) 
o It is produced by the same gene that produces the neuronal 
AChE. 
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o They two enzymes differ in their posttranslational 
modification. The RBC enzyme is a monomer bound to the 
GPI-linked proteins of the cell membrane. Whereas, the 
neuronal enzyme is in secretory form. It binds with other 
enzyme molecules to form dimers and tetramers that attach 
to the post synaptic neuronal membrane.  
o The RBC AChE activity tends to correlate accurately with 
the enzyme activity at the NMJ.49 
There are significant interindividual and inter OP variability with 
respect to the degree and duration with the organophosphates inhibit the 
AChE. After an acute exposure , the BuChE levels fall first followed by 
the RBC cholinesterase levels. In most patients both the enzyme levels 
will be low by the time they present to the hospital. There are interspecies 
variabilities in BuChE and AChE and this makes interpretations of animal 
models very difficult. The concentration of AChE enzyme in human 
plasma is very low. All studies that cite serum AChE activity are likely 
measuring the Butyrylcholinesterase levels.  
BUTYRYLCHOLINESTERASE  
After a mild exposure to OP, without any reexposures, the BuChE 
activity recovers earlier than the RBC AChE. The BuChE levels are less 
specific for OP exposure compared to the RBC levels. Low BuChE is 
also seen50 in 
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• Hereditary deficiency of BuChE 
• Malnutrition 
• Liver parenchymal disease 
• Chronic debilitating illnesses 
• Iron deficiency anemia. 
The reference range for this enzyme is wide. So a patient with high 
normal baseline levels might have the enzyme levels within the reference 
range despite a fall in levels after an exposure to OPs. The day to day 
variability in enzyme levels is also high, about 20% in healthy 
individuals. The inhibition of BuChE varies between OPs and it does not 
have any clinical effects. So, the BuChE levels on admission donot 
predict the outcome of the patients.  
RED CELL ACETYLCHOLINESTERASE 
The AChE in the red cells is the true AChE, and it accurately 
correlates with the enzyme activity in the nervous tissue. Studies suggest 
that clinical OP poisoning occurs when the RBC cholinesterase activity 
falls below 50% of baseline15. Neuromuscular dysfunction is seen when 
the levels fall below 30% of the baseline values49. The advantage of the 
red cell cholinesterase is that its activity can be related to the 
haemoglobin concentration, thus reducing the variation due to varying 
PCV51.  
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Normal values 600 to 700 mU/µmol Hb. A study in Caucasians noted a 
mean value of 651+/- 18 mU/µmol Hb. 
After an episode of poisoning the red cell AChE levels take several 
weeks to recover, in the absence of oxime therapy. On an average it takes 
66 days for the enzyme levels to normalize following a severe inhibition 
(assuming no therapy with oximes). Patients can have a normal NMJ 
function, no cholinergic features , yet a low red cell cholinesterase levels; 
this is because the neuronal AChE recovers faster than the red cell 
enzyme. Therefore in subacute poisoning a low red cell AChE alone 
cannot be used to predict actual time of onset or the duration of exposure.  
The red cell cholinesterase levels can reduce in other conditions like 
pernicious anemia, treatment with anitdepressants or with antimalarials.  
MEHOD OF BLOOD SAMPLE COLLECTION 
• Fluoride containing tubes should not be used. Fluoride permanently 
inactivates the enzyme, resulting in falsely low values. 
• Specimens for estimation of red cell AChE must collected in 
EDTA containing tubes. 
• Specimens for BuChE estimation can be drawn into plain tubes , 
the enzyme is estimated in the serum. 
• OPs and oximes in the blood sample can interact with each other. 
Small differences in time can cause wide variation in the result. 
Hence, the blood sample must be diluted with cold saline to ratio of 
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1:20 or 1:100 at bed side and is then rapidly frozen. Such 
preparations are not necessary for BuChE estimation.  
 
PROTEIN ADDUCTS 
     Researches are underway to identify tests to detect OP exposure 
many weeks after the event. Newer techniques like spectrophotometry 
are being employed to identify phosphorylated proteins in blood like 
albumin or BuChE52.  
 
  
 
 
CNS , central nervous system. RBC , red blood cell. 
INTERPRETATION OF CHOLINESTERASE LEVELS 
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ATROPINE CHALLENGE 
          Atropine may be helpful in diagnosing a patient presenting with 
cholinergic crisis when there is no clear history of excessive exposure to 
OP or carbamates. If an individual is not exposed to significant quantities 
of insecticide then a test dose of atropine,1 mg should be able to produce 
classical antimuscarinic signs- tachycardia, dry mucous membranes and 
mydriasis. Conversely, if the cholinergic features persist despite the test 
dose of atropine, then it strongly suggests the presence of an 
anticholinesterase poison15. However, in cases with mild poisoning, the 
test dose of 1mg of atropine might be able to produce antimuscarinic 
signs. Hence, the reversal of cholinergic signs doesn’t completely rule out 
a OP poisoning.   
 
ELECTROMYOGRAM STUDIES 
          Repetitive nerve stimulation is an accurate method of quantifying 
AChE inhibition at the neuromuscular junction. Spontaneous repetitive 
potentials or fasciculations following single nerve stimulation is a 
sensitive indicator of AChE inhibition at the motor end plate. This may 
be useful in the early diagnosis of OP poisoning. This testing is also 
useful for detecting rebound cholinergic crisis seen with lipophilic OPs 
and in case of intermediate syndrome.  
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DIFFERENTIAL DIAGNOSIS 
The differential diagnoses of a cholinergic poisoning fall into three 
main categories 
1. The first group comprises the insecticidal and non-insecticidal 
cholinesterase inhibitors. This includes pyridostigmine overdose 
seen in patients with myasthenia gravis. These patients have 
low levels of BuChE and AChE. 
2. Second category includes the cholimimetics. They directly 
stimulate the nicotinic and the muscarinic receptors. They have 
no effect on the AChE enzyme activity. The BuChE and red cell 
AChE levels should normal in these cases. Examples include 
preparations of methacholine, pilocarpine, bethanechol.  Non 
therapeutic agents like muscarinic mushrooms can be 
cholimimetic. 
3. The third group are the nicotine alkaloids- nicotine, obeline and 
coniine. They cause autonomic, skeletal muscle and CNS 
symptoms similar to that produced by the OPs and carbamate 
toxicities.  
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TABLE SHOWING CATEGORIES OF CHOLINERGIC 
POISONING 
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MANAGEMENT 
GENERAL PRINCIPLES 
 Most common cause of death in OP poisoning is due to respiratory 
failure.  
 Respiratory failure in OP poisoning occurs due to the following 
reasons 
o Muscarinic effects causing bronchospasm, bronchorrhea, 
bradycardia and hypotension. 
o Nicotinic effects resulting in paralysis of the diaphragm and 
the intercostal muscles. 
o Aspiration of the OP and coformulants causing aspiration 
pneumonia.  
o Loss of central respiratory drive.  
 Therefore, the primary goal of management is protecting the 
airway, maintaining the circulation and providing ventilator 
support.  
 This is achieved by antagonising the muscuranic effects  
 Airway maintainence is best achieved by endotracheal intubation 
and initiating mechanical ventilation if necessary.  
 Intubation is indicated in the following situations 
o Patients who are comatose 
o Patients with respiratory failure 
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o Patients who are unable to deal with the copious secretions. 
 If a paralyzing agent is needed, then it is recommended to use a 
non depolarizing agent53,54. Succinyl choline is degraded by plasma 
pseudocholineasterase, and hence its degradation will be reduced in 
case anticholinesterase poisoning resulting prolonged paralysis.  
 
ANTIMUSCARINIC THERAPY 
          Atropine is a competitive antagonist of acetylcholine at the 
muscarinic receptor. It reverses the muscarinic effects like, 
• Miosis 
• Salivation 
• Lacrimation 
• Diarrhea 
• Vomiting 
• Bronchospasm 
• Bronchorrhea 
• Bradycardia 
Dosing of atropine: 
          For adults and adolescents, initial doses should begin with 1-3 mg 
iv boluses repeated every 2 to 20 minutes till “atropinisation” occurs. A 
more practical regimen would be to double the dose of atropine every 5 
minutes till complete muscarinic blockade occurs. 
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For children, 0.05 mg/kg per dose is used with a minimum of 0.1 mg per 
dose. 
Signs of atropinisation: 
• Mydriasis 
• Tachycardia 
• Dry skin and mucous membranes 
• Absent or decreased bowel sounds 
• No bronchospasm 
Since the goal of muscarinic blockade is to stabilise the 
cardiorespiratory status, the more practical end points for atropinisation 
shall be, 
1. Pulse rate >80 bpm 
2. Systolic BP >90 mm of Hg 
3. No bronchospasm 
4. Clear lungs on auscultation. 
All the above parameters can be rapidly and easily assessed  
Atropine infusion: 
Once the desired muscarinic blockade is achieved, atropine is 
continued as an infusion. Dose is 10 to 20% of the initial bolus dose is 
infused every hour , not exceeding 2mg/hr. children need 0.025mg / kg/ 
hr infusion.  
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Patients should be periodically monitored for signs of under or 
over atropinisation and boluses of atropine are administered or the 
infusion rate is halved accordingly. 
Atropine infusions are particularly needed in cases of severe 
poisoning by fat soluble OPs that continue to release from the fat stores. 
There is case report stating that such infusion has been used as long as 32 
days.55 
Large doses of atropine are required to control the lung secretions 
in severe cases. On an average, such patients may require 40 mg of 
atropine. Sometimes even 1000mg of atropine may be needed in 24 hrs56. 
there are literature reports that say the a total cumulative dose 11000mg 
of atropine was used in a patient.  
Atropine does not reverse the nicotinic effects. So the patients must 
regularly monitored for the development of proximal muscle weakness. If 
it occurs, sixth hourly monitoring of tidal volume is recommended for 
early diagnosis and treatment of respiratory failure.  
Excessive administration of atropine results in  toxicity. Signs toxicity 
are: 
• Tachycardia 
• Hyperthermia 
• Absent bowel sounds 
• Confusion and delirium 
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• Mydriasis 
     When these signs are present, the dose of atropine must be reduced. 
It is to be noted that tachycardia per se is not a contraindication for 
atropine because it may be due to many other causes like aspiration 
pneumonia, hypotension, hypoxia.  
Some patients may be develop CNS features of muscarinic 
blockade while the systemic cholinergic features may persist. In such 
circumstances, glycopyrrolate can be used instead of atropine. The dosing 
is similar to atropine, it is administered as 1 to 2 mg boluses that are 
repeated when required. Glycopyrrolate has a quaternary ammonium 
structure which prevents it from entering the central nervous system. As 
with atropine, much higher doses may be required in patients with severe 
poisoning. There is one randomized controlled trial that compared 
effectiveness of atropine with glycopyrrolate in ICU settings, but it was 
too small to produce any significant differences57.  
When the supply of atropine gets exhausted, topical preparations of 
atropine and other antimuscarinic agents like diphenhydramine may be 
used.  
OXIMES 
          The phosphorylated acetylcholinesterase undergoes regeneration at 
a very slow rate. The rate of regeneration can be speeded by oximes. This 
lowers concentration of the ACh at the nerve synapses and NMJ , thus 
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reducing the nicotinic and muscarinic stimulation thereby providing 
symptomatic relief. Oxime administration rapidly increases the RBC 
AChE levels paralleling the rise in neuronal AChE levels.  
The currently available oximes are: 
1. Monopyridium oximes 
a. Pralidoxime (2-PAM) 
2. Bispyridium oximes 
a. Obidoxime  
b. Trimedoxime(TMB-4) 
c. Asoxime (HI 6) 
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STRUCTURE OF OXIMES 
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STRUCTURE OF OXIMES (contd.) 
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Dosing of oximes: 
A recent clinical trial in India demonstrated that high dose oxime 
therapy was able to reduce the duration of mechanical ventilation and 
improve the mortality in patients with moderate poisoning.  
2 g of pralidoxime58 mixed in 100 ml of 0.9% saline is infused over 
30 minutes. This is followed by a continuous infusion of 8-10 mg /kg/hr 
infusion.  
The infusion is continued till there is no atropine requirement for 
12 to 24 hours. It is important to monitor for recrudescence of cholinergic 
symptoms following cessation of oxime therapy. If it should occur then 
oxime therapy can be repeated for another 24 hours.  
Lipophilic OPs cause delayed onset symptoms. In such cases trial 
evidence favours a delayed initiation of oxime therapy. This approach 
reverses the cholinergic signs and is able to prevent respiratory failure.  
Monitoring of therapy can be done by: 
• Measurements of OP levels in blood and urine. 
• Serial measurements of plasma cholinesterase 
• Incubating patient patient serum with normal RBC to check for 
inhibition of the enzyme in the normal RBC. 
• Incubating patients RBC in vitro with oxime to look for 
reactivation of the cholinesterase in RBC.  
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DIAGRAM SHOWING MECHANISM OF ACTION OF OXIMES 
AND REGENERATION OF FREE CHOLINESTERASES 
 
 
 
 
 
 
 
 
 
59 
 
Adverse effects of oximes: 
Therapeutic dose of oximes donot cause any significant reactions. 
Tachycardia, blurring of vision, rise in diastolic blood pressure, sudden 
cardiac arrest and laryngospasm may occur on rapid I.V. administration.  
Oximes are classified under category C in pregnancy. Oxime 
administration to pregnant women protects both the mother and the fetus, 
in the event of a poisoning.  
 
BENZODIAZEPINES 
Although animal studies have demonstrated benefit on treating 
with benzodiazepines along with oximes59, to date no human studies were 
able to demonstrate a benefit with the same. Therefore routine 
administration of benzodiazepines is not recommended in humans. They 
can be used to treat seizures, aid intubation and to sedate agitated 
patients.  
 
DECONTAMINATION 
1. Cutaneous absorption of OPCs  necessitates removal of allclothing 
as soon as possible. 
2. Medical personnel should avoid self-contamination by 
wearingneoprene or nitrile gloves. Double gloving with standard 
vinyl gloves may be protective. 
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3. Skin should be triple washed with water, soap, and water, and 
rinsed again with water. Although alcohol-based soaps are 
sometimes recommended to dissolve hydrocarbons, these products 
can be difficult to find, and expeditious skin cleansing should be 
the primary goal. 
4. Cutaneous absorption can also result from contact with OPCs 
andcompounds in vomitus and diarrhoea if the initial exposure was 
by ingestion. 
5. Oily insecticides may be difficult to remove from thick or long 
hair, even with repeated shampooing, hence shaving scalp hair may 
be necessary. 
6. Exposed leather clothing or products should be discarded because 
decontamination is very difficult once impregnation has occurred. 
7. In some military institutions the cholinesterase impregnated sponge 
is found to be effective in cutaneous OPCs 
8. Although the Activated charcoal is useful in some studies a recent 
study shows that activated charcoal in multiple doses offer no 
benefit and hence once the risk of aspiration is ruled out the AC in 
a dose of 1gram/kg as a single dose is recommended.61 
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QT INTERVAL 
The QT interval is the interval measured in the electrocardiogram. 
It extends from the beginning of the QRS complex to the end of the T 
wave. The QT interval incudes the ventricular activation and recovery 
phases. Thus , it corresponds to the entire duration of the ventricular 
action potential.  
 
 
 
 
Diagram showing a magnified long axis view point of various 
waveforms and intervals. 
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However there exist a few practical difficulties in measuring the 
QT interval. They are as follows: 
 Difficulty in identifying the beginning of the QRS and the end of T 
wave. 
 The timing of the QRS complexes varies between the precordial 
leads.  
 The QT interval has to be adjusted for age, QRS duration, sex and 
most importantly the heart rate62.  
The variation in the timing of the QRS complexes and the T wave 
among the leads can result in a variation of about 50 milliseconds to 65 
milliseconds in the QT interval measurement. Automated ECG machines 
calculate the QT interval in all the leads and finally compute an average 
of the readings. While calculating the QT interval manually, one must 
choose the lead where the QRS begins early and the T wave ends late- 
typically the leads V2 and V3 and also a lead where the U waves are not 
prominent like the lead aVr.  
 
QT INTERVAL CORRECTION FOR HEART RATE 
QT interval varies markedly with heart rate. As the heart rate 
increases, the QT interval shortens. In the year 1920, Bazett described a 
formula the correction of the influence heart rate on the QT interval. 
QTC=QT/√(R-R interval) 
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Where the QT interval and the R-R interval are measured in 
seconds. Even after this correction, the Bazett’s formula tends to 
overestimate the QT interval resulting in erroneous diagnosis of a 
prolonged QT interval. The variation may be as much as 30% , as 
estimated in various studies. A newer formula has been described to make 
the QT interval insensitive to the heart rate62, 
QTC= QT+1.75*(HR-60) 
QTc  - corrected QT interval 
HR – heart rate.  
All units measured in milliseconds.  
The ACC/AHA have prescribed the upper limit for QTc as 460 ms 
in females and 450 ms in males while the lower limit has been fixed at 
390 ms. Apart from variations with HR, it also varies with age, time of 
the day and even the season. Older individuals have cardiac myocyte 
hypertrophy (compared to younger individuals) and therefore have a 
longer ventricular activation and recovery times, culminating in longer 
QT intervals.  
QT interval prolongation and shortening can occur in various 
syndromes. A meta analysis of 23 studies has shown that a prolongation 
of the QT interval by 50 milliseconds increases the all cause mortality 
1.20 times and the cardiovascular mortality by 1.29 times from baseline63.  
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QT INTERVAL IN ACUTE OP POISONING66, 67, 71 
The relationship between QT interval and acute OP poisoning is 
still uncertain. Baydin et al had reported that 35.4% of patients admitted 
with OP poisoning had prolonged QTC intervals. Their study, however, 
found a negative correlation between the QTC interval and serum 
cholinesterase levels. Yurumez et al analysed the hospital records of 85 
patients admitted with OP poisoning and found that 47 patients i.e. 56% 
had a prolonged QT interval. However, the 2 patients who died in the 
study had normal QTC intervals.  
Akdur et al found that 53.6% of patients with acute OP poisoning 
had prolonged QT interval, but they could not find a relationship between 
the prolonged QT interval and the outcome of the patients. In Taiwan, 
Liu-SH et al had studied the QT interval of 118 patients and they 
compared the mortality in the patients with normal QTC interval with that 
in patients with prolonged QTC intervals. They found a higher mortality 
in patients who had prolonged QTC intervals. Thus, they finally 
concluded that the QTc interval helps to predict outcomes after acute 
organophosphate poisoning.  
In this study we aim to study the relationship between the QT 
interval and the outcome of the patients with OP poisoning.  
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GLASGOW COMA SCALE 
The Glasgow Coma Scale , abbreviated as GCS, was initially 
described as a bed side tool to assess the mental status of patients 
admitted with head trauma. It served as a valuable tool in triaging head 
trauma patients brought to the casualty. Further it was a good predictor of 
outcome in those patients.  
The GCS is a score calculated using three parameters: 
 Eye opening response – scored from 1 to 4 
 Best verbal response – scored from 1 to 5 
 Best motor response – scored from 1 to 6. 
The minimum score for a patient is 3 and the maximum is 15. Total 
score is calculated by adding the scores of the three components 
described above.  
 
Table: showing the components of GCS 
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Apart from head trauma , GCS is also used to assess the conscious 
level of patients in anesthesia, in those presenting in an obtunded state to 
assess the need for emergent airway management , monitoring the 
progress of unconscious patients. It is an established indication that a 
patient with a GCS score of less than 7 needs intubation for airway 
protection.  
Ezadi Mood et al in 2011 showed that admission GCS score can be 
validated for the assessment of patients with mixed poisoning. A 
poisoned patient can a have rapid changes in conscious levels owing to 
number of factors thereby making the utility of GCS questionable; but 
numerous studies have demonstrated the usefulness of GCS and its 
components in predicting the severity and the outcomes in poisoned 
patients72. Grmec and colleagues demonstrated that the GCS scores in OP 
poisoned patients was lower among the non survivors compared to the 
survivors70. Akdur et al had compared the effectiveness of Poison 
Severity Score and GCS in acute OP poisoning and concluded that both 
the parameters were reliable predictors of patient outcome64.  
In our study we aim to study the relationship between GCS and the 
patient outcome in acute OP poisoning.  
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MATERIALS AND METHODS 
SELECTION OF PATIENTS 
Patients admitted to Rajiv Gandhi Government General hospital 
Toxicology Unit are selected based on the inclusion criteria. Any patient 
with a clear history of consumption of an organophosphorus insecticide 
was included in the study. Patients presenting with acute cholinergic 
crisis with a characteristic smell of OP in the stomach wash, patients 
whose gastric content analysis confirms OP consumption were also 
included in the study. Since the study design is prospective as well as 
retrospective observational one, the patient records of the Rajiv Gandhi 
Government General Hospital were also included.  
STUDY CENTER 
Toxicology Unit , Rajiv Gandhi Government General Hospital,  
Park town, Chennai- 600003. 
DURATION OF STUDY 
6 months 
STUDY DESIGN 
Prospective and Retrospective Observational Study. 
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SAMPLE SIZE 
50 patients 
DATA COLLECTION AND METHODS 
Patients admitted to the toxicology unit are subjected to thorough 
history taking and clinical examination. Routine blood investigations are 
taken as per the institution protocol. ECG is also taken. Retrospective 
data are obtained from the case records in the medical records 
department.  
INCLUSION CRITERIA 
1. Any patient with known or suspected organophosphate poisoning , 
identified as below 
a. History of consumption of an OPC insecticide 
b. Classical clinical features of cholinergic crisis – miosis, 
hypersalivation, fasciculations, characteristic odour of 
stomach wash. 
c. Gastric analysis positive for OP.  
2. Identification of the container of the compound consumed. 
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EXCLUSION CRITERIA 
1. Patients who have consumed other poisons with the opc. 
2. Patients who have consumed alcohol. 
3. Patients with pre existing cardiac disease or chronic lung disease 
4. Coma due to trauma. 
5. Patients with hypoglycemia or hypothermia. 
6. Patients with liver cell failure, renal failure 
 
METHODOLOGY 
Patients admitted with organophosphate poisoning- selected for 
study based on the inclusion and exclusion criteria. A detailed physical 
examination is done with special emphasis on the GCS of the patient on 
admission. All patients were subjected to routine blood tests – CBC, RFT 
and blood sugar levels and ECG. QTc interval is calculated based on 
admission ECG, using the Bazett’s formula. 
QTC=QT/√(R-R interval) 
Patients were divided into two groups –  
• Group A includes patients without respiratory failure and  
• Group B includes patients with respiratory failure. 
The GCS and QTc intervals in these two groups are compared with 
each other. 
 STATISTICAL METHODS
The statistical analysis is done using SPSS software. 
valueobtained is analysed using the SPSS software
SPONSORSHIP 
 
FLOW CHART DESCRIBING THE 
TOTAL NO OF PATIENTS n=50
APPLYING INCLUSION AND 
EXCLUSION CRITERIAS
OBTAINING THE NECESSARY 
CLINICAL AND LAB 
PARAMETERS
CALCULATING GCS AND QTc 
INTERVAL
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– None ; CONFLICT OF INTEREST
METHOD OF STUDY 
COMPARING THE PARAMETERS 
BETWEEN THE TWO GROUPS
The ‘p’ 
 – None 
 
 
 SEX WISE DISTRIBUTION
 
SL. NO. 
NUMBER 
PERCENTAGE 
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MALE FEMALE 
38 12 
76% 24% 
MALE FEMALE
SEX DISTRIBUTION
TOTAL 
50 
100% 
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AGE WISE DISTRIBUTION 
 
SL. NO. AGE GROUP(yrs.) No. of Patients 
1. 15 – 30 yrs 22 
2. 30 – 45 yrs 11 
3. 45 – 60 yrs 14 
4. 60 – 75 yrs 3 
 
 
In our study , 66% of the patient population were under the age of 
45 years. The oldest patient in our study was 65 years of age. The 
youngest patient was 18 yrs of age. Patients under the age of 18 yrs were 
excluded from study.  
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HISTOGRAM SHOWING THE AGE 
DISTRIBUTION AMONG THE STUDY 
POPULATION 
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TABLE SHOWING THE COMPOUNDS CONSUMED BY THE  
PATIENTS. 
 
SL. NO. COMPOUND CONSUMED NO. OF PATIENTS 
1 DIMETHOATE 6 
2 MONOCROTOPHOS 9 
3 PHENTHOATE 4 
4 TRIZOPHOS 7 
5 METHYLPARATHION 9 
6 QUINOLPHOS 2 
7 CHLORPYRIPHOS 3 
8 FENTHION 4 
9 DICHLORVAS 2 
10 ACEPHATE 4 
 
 
 
 
  
GRAPH SHOWING THE DISTRIBUTION OF 
 
 
 
The most commonly consumed organophosphate compounds in 
our study were Monocrotophos and Methylparathion. The second most 
common compound
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COMPARISON OF GCS BETWEEN TWO GROUPS 
 
 GROUP A GROUP B 
MEAN 12.3636 6.5294 
STANDARD 
DEVIATION 
2.1333 1.588 
 
 
Group A – patients without respiratory failure. 
Group B – patients with respiratory failure. 
In our study the difference in GCS between the two groups of patients is 
significant with p value <0.001. 
 
 
 
 
 
 
 
 GRAPH COMPARING THE GLASGOW COMA SCALE 
BETWEEN THE TWO GROUPS
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COMPARISON OF THE QTc INTERVAL AMONG THE 
TWO GROUPS 
 
 GROUP A GROUP B 
MEAN QTc INTERVAL 
IN SECONDS 
0.4477 0.4967 
STANDARD 
DEVIATION 
0.01 0.007 
 
 
Group A – includes patients without respiratory failure. 
Group B – includes patients with respiratory. 
In our study the difference in the QTc interval between the two patient 
groups is significant with a p value of <0.001.( p value is calculated 
using student t test for two independent variables). 
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GRAPH SHOWING THE QTc INTERVALS IN THE TWO 
PATIENT GROUPS 
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COMPARISON OF GCS SCORE AMONG SURVIVORS
 
 
GCS SCORE 
 
The difference in GCS score among survivors and non survivors 
was significant with a
based on student t test for two independent variables.) 
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AND NON SURVIVORS 
SURVIVORS NON 
SURVIVORS
11.069 ± 3.08 5.8571 
 p value of <0.001. (the p value was calculated 
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 COMPARISON OF QTc INTERVAL 
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The difference in the QTc intervals between the survivors and non 
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DISCUSSION 
This is a prospective and retrospective observational study 
conducted at the Toxicology unit at Rajiv Gandhi Government General 
Hospital, Chennai. Patients who presented with a history of OP ingestion 
or with a documented evidence of OP poisoning were included in our 
study. A total of 50 patients who satisfied our inclusion criteria were 
included. Most of the severely poisoned patients were referred from the 
nearby government hospitals for intensive care management. Informed 
consent was obtained from the prospective study patients. The data for 
the retrospective study was obtained from the records of the Rajiv Gandhi 
Government Hospital. 
Organophosphate poisoning is a common mode of poisoning in 
India. It most commonly affects the rural population where access to 
health care is not as easy as in the urban areas. Respiratory failure is the 
most common cause of death in these patients. Hence it is important that 
patients with severe poisoning are identified early and referred to a 
facility with appropriate infrastructure for critical care as early as 
possible. Most of the severely poisoned patients need intubation and 
mechanical ventilator support and have to be monitored in an ICU setting. 
Multiple organ system involvement is common in OP poisoning since the 
Ach receptors are present in almost all organ systems.  
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GCS and QTc interval are calculated on admission. Many studies 
have quoted the usefulness of the above two parameters in predicting the 
development of respiratory failure. Patients with poisonings can have 
rapid changes in conscious level, thereby raising doubts regarding the 
usefulness of Glasgow Coma Scale in these patients. However, Ezadi 
Mood and colleagues demonstrated that GCS score on admission and its 
components can be used for patients with mixed poisoning to predict 
severity.  
Okhan Akdur and et al compared the effectiveness of Poison 
Severity Score , Glasgow Coma Scale and QTc interval in predicting the 
outcomes in OP poisoned patients. They found a correlation between 
GCS and PSS in identifying patients with severe poisoning. However, the 
prolongation of QT interval did not correlate with the severity in their 
study.  
In our study we found that the mean GCS score in patients with 
respiratory failure was significantly lower than in the patients without 
respiratory failure, with a p value of <0.001.  
The mean QTc interval was prolonged in patients who had 
respiratory failure compared to those without respiratory failure. The 
difference was significant with a p value of <0.001.  
The mortality rate in our study was 14%. We also compared the 
GCS and QTc intervals among the survivors and non survivors.  
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We found the mean GCS score of the non survivors was 
significantly lower than  the survivors. The p value was <0.001. 
The mean QTc interval was longer among the non survivors 
compared to the survivors, which was significant with a p value of 
<0.001.  
 
LIMITATIONS OF THE STUDY: 
1. A multicentre study with a larger patient group will be needed to 
confirm the usefulness of GCS and QTC interval in predicting 
outcomes in patients with acute OP poisoning.  
2. The studies should also be conducted in different population 
groups, in order to confirm their predictive value.  
3. Serum magnesium was not measured in the patients with prolonged 
QTC intervals.  
4. The small sample size of  is also a limitation of our study.  
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CONCLUSION 
In our study we thus conclude that Glasgow Coma Scale and heart 
rate corrected QT interval measured from admission ECG are useful 
predictors of respiratory failure and mortality in patients with acute OP 
poisoning. The patients who developed respiratory failure had prolonged 
QTC intervals and lower GCS scores and the same was also seen with the 
patients who succumbed to the poisoning. Hence, in patients with acute 
OP poisoning, a low GCS score and a prolonged QTC interval on 
admission is associated with a poor outcome.  
 
 
 
 
 
